PBX3 and acute myeloid leukemia: These include histone methylation in promoter and enhancer regions of PBX3 [10,11], as well as DNA methylation as revealed by a significant increase in PBX hypomethylation in CBFP-MYH11-rearranged acute myeloid leukemia (AML) [12].